<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Four patients diagnosed with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease developing neurologic manifestation are described </plain></SENT>
<SENT sid="1" pm="."><plain>Central <z:mp ids='MP_0008912'>nervous</z:mp> system findings were observed in three of them and <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> in ther other patient </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients were treated with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi>, 0.1-0.2 mg/kg/day as initial dose </plain></SENT>
<SENT sid="3" pm="."><plain>Three of them ended the immunosuppressive therapy after a period of treatment between 12-18 months </plain></SENT>
<SENT sid="4" pm="."><plain>None of the four patients suffered neurologic relapses once that the therapy with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> was started </plain></SENT>
<SENT sid="5" pm="."><plain>In a similar way to other authors, we think that treatment with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> in neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease may be useful to reduce morbility related to neurologic relapses </plain></SENT>
</text></document>